Large text / Standard text
Aimspro® / Ceremben® / Information for doctors / Trials information / FAQs / News / Links / About Daval / Contact
Manufacturing Process (GMP) / Safety
Safety
As our mission statement confirms, product safety is the principal concern of Daval International Limited.
Medical practitioners prescribing this unlicensed product under the various national Special Access Schemes are reminded of the fact that most countries operate a Side Effect and Adverse Events Reporting System. In the United Kingdom, the MHRA operates a "Yellow Card" system, which enables swift reporting of adverse effects.
Back to AIMSPRO
As our mission statement confirms, product safety is the principal concern of Daval International Limited.
Medical practitioners prescribing this unlicensed product under the various national Special Access Schemes are reminded of the fact that most countries operate a Side Effect and Adverse Events Reporting System. In the United Kingdom, the MHRA operates a "Yellow Card" system, which enables swift reporting of adverse effects.
Back to AIMSPRO
